Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.
27 August 2022 (16:14 - 16:30)
Organised by:
Slides
About the speaker
Kyoto Prefectural University of Medicine, Kyoto (Japan)
4 More presentations in this session
Doctor A. Issa (Rio de Janeiro, BR)
Associate Professor F. Guerra (Ancona, IT)
Doctor G. Benetos (Athens, GR)
Access the full session
The Event
ESC Congress 2022
27 August 2022
16:14 CET
You may be interested in
Congress Presentation
Congress Presentation
